Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
RHEUMATOLOGY / LETTER TO THE EDITOR
Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata
1
Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, Hunan, China
Submission date: 2024-04-11
Final revision date: 2024-05-16
Acceptance date: 2024-05-18
Online publication date: 2024-06-30
Corresponding author
Li Deng
Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University，zhuzhou，hunan, zhuzhou, China
Department of Rheumatology and Immunology, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University，zhuzhou，hunan, zhuzhou, China
Arch Med Sci 2024;20(3):1050-1052
TOPICS
REFERENCES (10)
1.
Lu Q, Long H, Chow S, et al. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus. J Autoimmun 2021; 123: 102707.
2.
Zhang H, Yang NS, Lu J, et al. Recommendations for the diagnosis and management of lupus nephritis in China. Zhonghua Nei Ke Za Zhi 2021; 60: 784-90.
3.
Fornaro M, Coladonato L, Venerito V, Cacciapaglia F, Lopalco G, Iannone F. Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus. Rheumatol (Oxford) 2019; 59: 1792.
4.
Zhang J, Qi F, Dong J, Tan Y, Gao L, Liu F. Application of baricitinib in dermatology. J Inflamm Res 2022; 15: 1935-41.
5.
Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol 1992; 128: 368-71.
6.
Kridin K, Shalom G, Comaneshter D, Cohen AD. Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study. Immunol Res 2020; 68: 1-6.
7.
Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019-27.
8.
Elela MA, Gawdat HI, Hegazy RA, et al. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata. Arch Dermatol Res 2016; 308: 115-21.
9.
Kuwano Y, Fujimoto M, Watanabe R, et al. Serum BAFF and APRIL levels in patients with alopecia areata. J Dermatol Sci 2008; 50: 236-9.
10.
Shi F, Xue R, Zhou X, Shen P, Wang S, Yang Y. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease. Immunopharmacol Immunotoxicol 2021; 43: 666-73.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
